A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT).
机构:[1]Chinese Univ Hong Kong, Dept Clin Oncol, State Key Lab Oncol South China, Hong Kong, Peoples R China;其他部门华南肿瘤学国家重点实验室中山大学肿瘤防治中心[2]Chinese Univ Hong Kong, Hong Kong Canc Inst, Dept Clin Oncol,Sir YK Pao Ctr Canc, Partner State Key Lab Oncol South China,Shatin, Hong Kong, Peoples R China;其他部门华南肿瘤学国家重点实验室中山大学肿瘤防治中心[3]Chinese Univ Hong Kong, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China;[4]Queen Elizabeth Hosp, Dept Clin Oncol, Hong Kong, Peoples R China;[5]Tuen Mun Hosp, Hong Kong, Peoples R China;[6]Princess Margaret Hosp, Dept Oncol, Kowloon, Hong Kong, Peoples R China;[7]Pamela Youde Nethersole Eastern Hosp, Dept Clin Oncol, Chai Wan, Hong Kong, Peoples R China;[8]Univ Hong Kong, Queen Mary Hosp, Dept Clin Oncol, Hong Kong, Peoples R China;[9]Chinese Univ Hong Kong, Hong Kong Canc Inst, Dept Clin Oncol,Sir YK Pao Ctr Canc, State Key Lab Oncol South China,Shatin, Hong Kong, Peoples R China;其他部门华南肿瘤学国家重点实验室中山大学肿瘤防治中心[10]Tuen Mun Hosp, Dept Clin Oncol, Tuen Mun, Hong Kong, Peoples R China;[11]Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China;[12]Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China;[13]Prince Wales Hosp, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China;[14]Chinese Univ Hong Kong, Prince Wales Hosp, Dept Imaging & Intervent Radiol, Hong Kong, Peoples R China;[15]Chinese Univ Hong Kong, Dept Clin Oncol, Sir YK Pao Ctr Canc, State Key Lab Oncol South China,Shatin, Hong Kong, Peoples R China;其他部门华南肿瘤学国家重点实验室中山大学肿瘤防治中心[16]Chinese Univ Hong Kong, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China;[17]Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China
第一作者机构:[1]Chinese Univ Hong Kong, Dept Clin Oncol, State Key Lab Oncol South China, Hong Kong, Peoples R China;[2]Chinese Univ Hong Kong, Hong Kong Canc Inst, Dept Clin Oncol,Sir YK Pao Ctr Canc, Partner State Key Lab Oncol South China,Shatin, Hong Kong, Peoples R China;[3]Chinese Univ Hong Kong, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China;[4]Queen Elizabeth Hosp, Dept Clin Oncol, Hong Kong, Peoples R China;[5]Tuen Mun Hosp, Hong Kong, Peoples R China;[6]Princess Margaret Hosp, Dept Oncol, Kowloon, Hong Kong, Peoples R China;[7]Pamela Youde Nethersole Eastern Hosp, Dept Clin Oncol, Chai Wan, Hong Kong, Peoples R China;[8]Univ Hong Kong, Queen Mary Hosp, Dept Clin Oncol, Hong Kong, Peoples R China;[9]Chinese Univ Hong Kong, Hong Kong Canc Inst, Dept Clin Oncol,Sir YK Pao Ctr Canc, State Key Lab Oncol South China,Shatin, Hong Kong, Peoples R China;[10]Tuen Mun Hosp, Dept Clin Oncol, Tuen Mun, Hong Kong, Peoples R China;[11]Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China;[12]Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China;[13]Prince Wales Hosp, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China;[14]Chinese Univ Hong Kong, Prince Wales Hosp, Dept Imaging & Intervent Radiol, Hong Kong, Peoples R China;[15]Chinese Univ Hong Kong, Dept Clin Oncol, Sir YK Pao Ctr Canc, State Key Lab Oncol South China,Shatin, Hong Kong, Peoples R China;[16]Chinese Univ Hong Kong, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China;[17]Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China
推荐引用方式(GB/T 7714):
Chan Anthony T. C.,Hui Edwin Pun,Ngan Roger K. C.,et al.A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT).[J].JOURNAL OF CLINICAL ONCOLOGY.2017,35:-.doi:10.1200/JCO.2017.35.15_suppl.6002.
APA:
Chan, Anthony T. C.,Hui, Edwin Pun,Ngan, Roger K. C.,Tung, Stewart Yuk,Cheng, Ashley Chi Kin...&Lo, Y. M. Dennis.(2017).A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT)..JOURNAL OF CLINICAL ONCOLOGY,35,
MLA:
Chan, Anthony T. C.,et al."A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT).".JOURNAL OF CLINICAL ONCOLOGY 35.(2017):-